Stem Cell Technology

AmStem Investor Presentation

Download or view AmStem Investor Presentation January 2010
"Fulfilling the worldwide promise of stem cells"

AmStem Highlights

Home

Technology

AmStem’s Matrix of Stem Cell Technology

While there are other biotechnology companies out there developing stem cell commerce, there are none that have AmStem’s unique combination of patented science, established supply chain and vast stockpile of raw materials, regulatory approval, and products ready for market NOW.

By having its own complete matrix of technology, AmStem qualifies as one of the most advanced and self-sufficient Stem Cell biotechnology companies in the world.

Cord Blood Bank

AmStem controls the largest, fully accredited Cord Blood Bank in existence (more than twice as large as its nearest competitor). Umbilical cord blood is not only a very popular source of stem cells for research and treatment, but provides a steady supply of raw material for our own research and product development. See more

Clinical Trials

AmStem oversees some of the most advanced Clinical Trials in the world that are already using stem cells derived from cord blood to treat many incurable diseases. Histostem Ltd. of Korea (a 90% owned subsidiary) has full approval from the Korean FDA to treat emergency patients with stem cells for virtually any intractable condition. See more

Hair Restoration

Histostem already has a domestic (Korean) patent for a novel procedure for Hair Restoration that has shown remarkable success in Korea. They also have Korean FDA approval for this cosmetic treatment, and patients are seen in a luxurious facility - the Seoul Cosmedi Spa. AmStem plans to make this treatment available closer to the U.S, in a resort location to be identified in a forthcoming Press Release. See more

Patents

AmStem controls the Patents for the methods used to create its lines of business, and has many other patents pending. Patents include methods of isolating stem cells from umbilical cord blood (frozen or fresh), medical treatments using proprietary technology, and various laboratory techniques. See more

Publications

Dr. Hoon Han, President and Founder of Histostem Ltd., has authored or co-authored many Publications in major scientific journals. These articles firmly establish Dr. Han as one of the leading stem cell scientists in the world. See more

Certifications

AmStem’s strength is that its subsidiary, Histostem, has taken “the high road” with everything it does, including the procurement of laboratory and regulatory Certifications of the highest order. AmStem has the management expertise to obtain reciprocal regulatory certifications (where necessary), and to leverage Histostem’s validity and compliance to achieve international success. See more